Viking Therapeutics stock skyrocketed and is up 120% on Tuesday. This comes after the company reported positive results in a mid-stage trial of a treatment for non-alcoholic fatty liver disease.
The main goal of the treatment is to reduce cholesterol and liver fat in patients.
Viking, with a market cap of around $1.3billion, is up 156% this year in comparison to just a ‘mere’ 8% for the S&P500!
Should the price close at these levels, the company might be holding the title of one of the biggest stock price gains in a single trading day in history.